α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
2018
Marcela Brissova | Rachana Haliyur | Diane Saunders | Shristi Shrestha | Chunhua Dai | David M. Blodgett | Rita Bottino | Martha Campbell-Thompson | Radhika Aramandla | Gregory Poffenberger | Jill Lindner | Fong Cheng Pan | Matthias G. von Herrath | Dale L. Greiner | Leonard D. Shultz | May Sanyoura | Louis H. Philipson | Mark Atkinson | David M. Harlan | Shawn E. Levy | Nripesh Prasad | Roland Stein | Alvin C. Powers
Summary: Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual β cells and α cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant β cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D α cells was markedly reduced, and these cells had alterations in transcription factors constituting α and β cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of α-to-β cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia. : Brissova et al. find that β cells in the type 1 diabetic (T1D) pancreas maintain several functional and molecular features, but α cells have impaired glucagon secretion and an altered gene expression profile. These findings provide insight into the mechanism of α cell dysfunction in T1D. Keywords: type 1 diabetes, glucagon, insulin, pancreatic islet, alpha cells, human
显示更多 [+] 显示较少 [-]